Doctors Note Logo

Published on: 8/20/2026

When does age-related macular degeneration (AMD) start?

Age-related macular degeneration (AMD) is an eye condition that primarily affects older adults, with early signs typically appearing after age 50. The risk of developing AMD rises significantly with age, making adults over 50 the most vulnerable group. Other risk factors include family history, smoking, high blood pressure, and prolonged sun exposure.

If you're over 50 and noticing changes in your central vision—such as blurriness, distorted lines, or difficulty recognizing faces—it's important not to wait. Early detection is key to slowing AMD's progression and preserving your sight. Take a free, instant, online symptom check to better understand your symptoms and confidently navigate your next steps.

Reviewed for medical accuracy: 07/15/2026

answer background

Quick answers

Frequently Asked Questions

4 answers

The most common questions people search after this page

Concerned about your symptoms?

Explanation

AMD is called "age-related" because it is most often seen in older people. The condition usually starts to show early changes in the retina after age 50, though many individuals may not notice any symptoms at the beginning. At first, small changes in the macula, the part of the retina that helps with sharp, detailed vision, can occur little by little. Over time, these changes can lead to more serious forms of AMD that might affect vision, especially the type known as neovascular AMD, which involves the growth of abnormal blood vessels. Risk factors such as genetics and lifestyle can also play a role, but age is a key factor. In short, while some early signs of AMD might start in mid-adulthood, the condition is most common and becomes a major concern in later years, often in the 70s and beyond. If you're experiencing vision changes or other concerning symptoms, consider taking a free symptom checker test to better understand your health, and regular eye checks can help catch early signs of AMD and guide proper management.

(References)

  • Pugazhendhi A, Hubbell M, Jairam P, Ambati B. Neovascular Macular Degeneration: A Review of Etiology, Risk Factors, and Recent Advances in Research and Therapy. Int J Mol Sci. 2021 Jan 25;22(3):1170. doi: 10.3390/ijms22031170. PMID: 33504013; PMCID: PMC7866170.

  • Ricci F, Bandello F, Navarra P, Staurenghi G, Stumpp M, Zarbin M. Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches. Int J Mol Sci. 2020 Nov 3;21(21):8242. doi: 10.3390/ijms21218242. PMID: 33153227; PMCID: PMC7662479.

  • Shao J, Choudhary MM, Schachat AP. Neovascular Age-Related Macular Degeneration. Dev Ophthalmol. 2016;55:125-36. doi: 10.1159/000438969. Epub 2015 Oct 26. PMID: 26501146.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.